1. Tularemia vaccines
- Author
-
Daniela Putzova, Jiri Stulik, and Iva Senitkova
- Subjects
0301 basic medicine ,030106 microbiology ,Disease ,Microbiology ,Airborne transmission ,Attenuated Live Vaccine ,Tularemia ,03 medical and health sciences ,Drug Discovery ,Animals ,Humans ,Medicine ,Subunit vaccines ,Francisella tularensis ,biology ,business.industry ,Infectious dose ,General Medicine ,bacterial infections and mycoses ,medicine.disease ,biology.organism_classification ,Virology ,030104 developmental biology ,Bacterial Vaccines ,Francisella ,business - Abstract
Francisella tularensis is the causative agent of the potentially lethal disease tularemia. Due to a low infectious dose and ease of airborne transmission, Francisella is classified as a category A biological agent. Despite the possible risk to public health, there is no safe and fully licensed vaccine. A potential vaccine candidate, an attenuated live vaccine strain, does not fulfil the criteria for general use. In this review, we will summarize existing and new candidates for live attenuated and subunit vaccines.
- Published
- 2016
- Full Text
- View/download PDF